Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Domain organization of mammalian Notch ligands. Five mammalian ligands ...
Expression and therapeutic potential of DLL3 in malignancies: a ...
DLL3 – A Breakthrough Target for Small Cell Lung Cancer Therapy-DIMA ...
Localization of chimeric DLL1 and DLL3 proteins. (A) Schematic ...
Dll3 Protein Atlas at Bryan Riggs blog
The unique role of DLL3 in the notch signaling pathway. The Notch ...
POLYMORPHISMS IN THE DLL3 CODING SEQUENCE | Download Table
Copy number alteration of DLL3 in a subset of pancreatic cancer cell ...
Dll3 expression in T-cell development. (a) Real time PCR expression of ...
Investigational DLL3 & T-Cell Engager Technology for SCLC | DLL3 ...
DLL3 regulates Notch signaling in small cell lung cancer: iScience
Phenotypes and somite patterning of embryos with various Dll1 and Dll3 ...
DLL3 Gene - GeneCards | DLL3 Protein | DLL3 Antibody
Distribution and function of DLL3 in tumor cells. Notch signaling is ...
Representative images of DLL3 protein in small-cell lung cancer (x400 ...
DLL3 (delta-like protein 3) expression correlates with stromal ...
Dll3 cell autonomously inhibits N signaling. (A) NIH 3T3 cells ...
DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and ...
The divergent DSL ligand Dll3 does not activate Notch signaling but ...
DLL3 Recombinant Monoclonal Antibody- Cusabio
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in ...
Schematic representation of the human DLL3 mutations. The protein is ...
DLL3 expression in normal and tumor tissue. DLL3 protein expression via ...
DLL3 positively regulated P53 signaling pathway. | Download Scientific ...
Biological and immunological significance of DLL3 expression in ...
JCI - IL-18–secreting CAR T cells targeting DLL3 are highly effective ...
DLL3 expressions in various cancer cell lines. (a) Examination of DLL3 ...
DLL3 Inhibitors - Coggle Diagram
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell ...
Representative DLL3 prevalence (ie, >1% DLL3-expressing cells) by ...
1689 Evaluation of DLL3 Expression in Small Cell Lung Cancer by ...
Expression and survival analysis of DLL3. (A-C) IHC staining of DLL3 in ...
DLL3 ADC峰回路转，SCLC治疗突破有望
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell ...
Delta‐like ligand 3: A promising target against small cell lung cancer ...
Anti-DLL3 ADC - Creative Biolabs
DLL3: A New Molecular Target in Cancer - Cusabio
Biochemistry of Notch ligands and Notch receptors There are five Notch ...
DLL3: Emerging Target in Tumor Therapy Treatment Strategies | KACTUS
Delta-like Ligand 3 (DLL3) in Targeted Cancer Therapy
Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and ...
Taking a Bite Out of Small Cell Lung Cancer By Leveraging Precision ...
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary ...
DLL3：多赛道进击小细胞肺癌 DLL3概述Delta样配体3 (Delta-Like Ligand 3, DLL3)是Notch配体家族的 ...
Structure of the Notch ligands. Mammalian Notch ligands are single-pass ...
Novel mutations in DLL3, a somitogenesis gene encoding a ligand for the ...
The role of Notch signaling in T cell differentiation. DLL, Delta-like ...
The expression levels of delta‐like 3 (DLL3) in... | Download ...
Delta-like protein 3 expression and therapeutic targeting in ...
The morphological features of delta‐like 3 (DLL3) expression in GI‐NEC ...
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small ...
Targets and biomarkers for targeted therapy. DLL3, delta-like protein ...
Frontiers | Prevalence of Delta-Like Protein 3 in a Consecutive Series ...
Recombinant Human Delta-like protein 3 (DLL3), (Active)- CUSABIO
(PDF) DLL3: An emerging target in small cell lung cancer
Oncology Letters
Double immunofluorescence staining of delta‐like 3 (DLL3) and CHGA in ...
Organization of the Notch receptor and ligand domains in mammals. Notch ...
DLL3/CD3 T-cell engager | InOncology – Boehringer Ingelheim
Expression of delta-like protein 3 is reproducibly present in a subset ...
Our Collections – Sapien Biosciences
ESMO 2024: DLL-3 Targeted Therapy for Neuroendocrine Prostate Cancer
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is ...
Oncology Reports
小细胞肺癌的治疗靶点DLL3
靶向DLL3，安进/百济神州递交双特异性T细胞结合器临床申请 3月15日，中国国家药监局药品审评中心（CDE）官网公示， 安进 （Amgen ...
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager ...
(PDF) Influence of preanalytical variables on performance of delta-like ...
Analysis of Dll1-Dll3 chimeric ligands. (A) Schematic overview of ...
Targeting DLL3: Innovative Strategies for Tumor Treatment
Delta-like ligand 3 (DLL3): an attractive actionable target in tumors ...
包含δ样配体3（DLL3）抗原结合结构域的蛋白质及其用途的制作方法
Frontiers | Delta-Like Protein 3 Expression in Paired Chemonaive and ...
(PDF) Prognostic value of delta‑like protein 3 combined with thyroid ...
Targeting Delta-like Ligand 3 (DLL3) | Amgen Oncology
研究报告 | 靶向DLL3药物在研现状 DLL3靶点介绍DLL3是一种高度肿瘤选择性的细胞表面靶点，主要表达于神经或者神经内分泌肿瘤，包括小 ...
安进大胜「肺癌之王」
首个针对DLL3表达肿瘤的三抗：泽璟制药ZG006的临床试验申请获得FDA批准
DLL blocks the Notch signaling pathway. Abbreviations: DLL: Delta-like ...
Characterization of DLL3-positive circulating tumor cells (CTCs) in ...
Lung Cancer Biomarkers | Delta-like Ligand 3 (DLL3) | ACROBiosystems
